Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 16 Neoplasms 5 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Brain Neoplasms 3 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Gallbladder Neoplasms 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Xanthogranuloma, Juvenile 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Solid Tumors 1 Solid Tumor 1 Sarcoma, Clear Cell 1 Neoplasms, Unknown Primary 1 Microsatellite Unstable Colorectal Cancer 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Inflammatory Breast Neoplasms 1 Histiocytosis, Sinus 1 Histiocytosis, Langerhans-Cell 1 Histiocytic Sarcoma 1 Histiocytic Disorders, Malignant 1 Hematologic Neoplasms 1

Interventions

tebentafusp 1 dostarlimab 1 cobimetinib 1 cabozantinib 1 atezolizumab 1 Vemurafenib 1 Specimen Handling 1 Radiation Dose Hypofractionation 1 Diathermy 1 Crizotinib 1 Biopsy 1 ARQ 197 1 AMG 337 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Sarcoma, Clear Cell × cobimetinib × Clear all

NCT02968303 2020-06-05

COWBOY

Radboud University Medical Center

Phase 2 Unknown

Sarcoma, Clear Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡